New SEC Document(s) for Savient Pharmaceuticals

SEC Filing Alert Savient Pharmaceuticals has filed the following document(s) with the United States Securities and Exchange Commission. Mar 07, 2013 Form 4 / Bahrt, Kenneth HTML PDF Form 4 / Ferrari, Louis HTML PDF Form 4 / Hamill, John HTML PDF Form 4 / Gionco, David HTML PDF Form 4 / Crowley, Richard HTML PDF Form 4 / Yachmetz, Philip K HTML PDF Form 4 / Veitch, David HTML PDF View all SEC Filings

You are subscribed to Savient Pharmaceuticals Investor Relations' e-mail alerts as clotito+biotechdash@gmail.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. Savient Pharmaceuticals 400 Crossing Boulevard 3rd Floor , Bridgewater, NJ 08807 Service provided by Shareholder.com